ConductScience.org, home

Paper5113220

A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment.

Halpern BL and 4 others. Johns Hopkins Med J, 1971. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. Papers, record 5113220. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5113220

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment.
PubMed
Journal
Johns Hopkins Med J
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
2.08
iCite
Revised in PubMed
2016-11-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Halpern BLB L
2Char FF
3Murdoch JLJ L
4Horton WBW B
5McKusick VAV A

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aortic RuptureMajor topic
Marfan SyndromeMajor topic
Adolescent
Adult
Aortic Aneurysm
Child
Electrocardiography
Female
Follow-Up Studies
Hemodynamics
Humans
Male
Propranolol
Radiography
Sex Factors

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
37160466Prophylactic effect of angiotensin receptor blockers in children with genetic aortopathies: the early bird catches the worm.Clin Res Cardiol2023https://conductscience.org/library/papers/37160466PubMed
36049495Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.Lancet2022https://conductscience.org/library/papers/36049495PubMed
35233355An update of medical care in Marfan syndrome.Tzu Chi Med J2022https://conductscience.org/library/papers/35233355PubMed
35139623Intensive care unit management of uncomplicated type B aortic dissection in relation to treatment period: a retrospective observational study.J Yeungnam Med Sci2022https://conductscience.org/library/papers/35139623PubMed
34408505An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome.J Exp Pharmacol2021https://conductscience.org/library/papers/34408505PubMed
30765726In vivo characterization of doxycycline-mediated protection of aortic function and structure in a mouse model of Marfan syndrome-associated aortic aneurysm.Sci Rep2019https://conductscience.org/library/papers/30765726PubMed
29541693Ruptured abdominal aortic aneurysm repair in pediatric Marfan syndrome patient.J Vasc Surg Cases Innov Tech2018https://conductscience.org/library/papers/29541693PubMed
29270371Etiology and pathogenesis of the Marfan syndrome: current understanding.Ann Cardiothorac Surg2017https://conductscience.org/library/papers/29270371PubMed
29110304Beta-blockers for preventing aortic dissection in Marfan syndrome.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29110304PubMed
28607545The Genetics of Aortopathies in Clinical Cardiology.Clin Med Insights Cardiol2017https://conductscience.org/library/papers/28607545PubMed
25965707
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.
Am Heart J2015https://conductscience.org/library/papers/25965707PubMed
25109242β-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome.J Pediatr2014https://conductscience.org/library/papers/25109242PubMed
23198270Bicuspid aortic valve disease and ascending aortic aneurysms: gaps in knowledge.Cardiol Res Pract2012https://conductscience.org/library/papers/23198270PubMed
20425163The pathogenesis of aortopathy in Marfan syndrome and related diseases.Curr Cardiol Rep2010https://conductscience.org/library/papers/20425163PubMed
20351702Marfan syndrome. Part 2: treatment and management of patients.Nat Rev Cardiol2010https://conductscience.org/library/papers/20351702PubMed
20300261Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: A time for re-appraisal.Ann Pediatr Cardiol2008https://conductscience.org/library/papers/20300261PubMed
16325700Marfan's syndrome.Lancet2005https://conductscience.org/library/papers/16325700PubMed
9059160Evolving phenotype of Marfan's syndrome.Arch Dis Child1997https://conductscience.org/library/papers/9059160PubMed
8435232Elective replacement of the aortic root in Marfan's syndrome.Br Heart J1993https://conductscience.org/library/papers/8435232PubMed
3134980Diagnosing Marfan syndrome.Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/3134980PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5113220

GET https://conductscience.org/api/papers/v1/5113220/cited_by?page=2